Five recommendations from NPI health & medicine group

In a webcast on May 23, 2013, subcommittee chairs of the National Photonics Initiative (NPI)—a group representing industry, academe, and government that aims to raise awareness of photonics—presented recommendations for continued growth of a field that has a proven its ability to leverage investment for substantial payoff. Health & Medicine Working Group Chair Stephen Laderman, director of Agilent Technologies’ Molecular Tools Laboratory, discussed the value proposition for biophotonics (sensitivity, speed, precision, accuracy) and the impact photonics technologies have made and continue to make in biomedical research and cost-effective health care. He said that while the United States is the acknowledged leader in biophotonics, other nations are making significant investments and as a result the country has experienced a substantial loss of global market share and thousands of jobs.

He presented a number of recommendations:

1. Support photonics research by keeping in mind the fact that it has already enabled some of the most exciting biomedical discoveries achieved to date, and has much more to offer

2. Invest in the development a shared database (and standards for its use) to facilitate photonics-based biomedical research

3. Prioritize the development of imaging standards and software methods toward a goal of quantitative (rather than qualitative or semi-quantitative) analysis

4. Fund development of affordable point-of-care diagnostic devices that meet real needs and will be embraced by medical practitioners

5. Support multidisciplinary efforts

Establishing the NPI was a key recommendation included the US National Academy of Sciences’ 2012 report, “Optics and Photonics: Essential Technologies for our Nation.” The initiative is spearheaded by the leading photonics societies: OSA, SPIE, APS, IEEE Photonics Society and LIA. According to Thomas Baer of Stanford Photonics Research Center, who chairs the NPI advisory committee and led the webcast, the group aims to “provide an opportunity to create the infrastructure for ongoing industry road mapping, economic impact analysis and improved interface between industry, academia, and government funding agencies.”

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Wearable light therapy device for hair loss receives regulatory approval in Brazil

The iGrow hair growth system, a wearable low-level light therapy device for treating hair loss, is cleared for use in Brazil.

FDA authorizes emergency use of Zika virus molecular detection assay

The xMAP MultiFLEX Zika RNA assay combines optofluidics and digital signal processing to detect Zika virus in vitro.

Merz acquires laser tattoo removal device maker ON Light Sciences

Merz North America has acquired ON Light Sciences, which develops technologies to enhance laser-based dermatology procedures.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS